Publications by authors named "S Ciurea"

Claim this Profile
O
Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis.
Chalothorn Wannaphut, Piyatida Chumnumsiriwath, Stefan O Ciurea, Piyanuch Kongtim

Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Stem Cell Transplantation for Multiple Sclerosis.
Shreya Condamoor, Pongthep Vittayawacharin, Michael Sy, Piyanuch Kongtim, Stefan O Ciurea

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.
Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine, Stefan O Ciurea

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax combined with cladribine, idarubicin, cytarabine (CLIA-VEN) results in higher remission rates over conventional 7 + 3 chemotherapy without increased toxicity in newly diagnosed acute myeloid leukaemia.
Benjamin J Lee, Shawn P Griffin, Jean Doh, Anthony Quach, Yujiao Sun, Stefan O Ciurea

Br J Haematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in measurable residual disease assessment for acute myeloid leukemia: from cytogenetics and molecular biology to assessment of the methylation pattern and surface-enhanced Raman scattering as emerging technologies.
Anamaria Bancos, Andrei Ivancuta, Vlad Moisoiu, Adrian-Bogdan Tigu, Diana Gulei, Stefan O Ciurea

Biomark Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis